Insmed INSM Enterprise value

Enterprise value at other companies

Sarepta Therapeutics, Inc.SRPT

$2.02B-67.2%

Solid Biosciences Inc.SLDB

$431.98M+333%

ANI PharmaceuticalsANIP

$1.72B+5.8%

Regeneron PharmaceuticalsREGN

$65.61B+15.0%

SavaraSVRA

$1.11B+127%

ArriVent BioPharma, Inc.AVBP

$958.05M+65.4%

FAQ

What is Insmed's enterprise value?

Insmed (INSM) reported enterprise value of $35.25B in Q1 2026.

How has Insmed's enterprise value changed year-over-year?

Insmed's enterprise value increased by 142.3% year-over-year, from $14.55B to $35.25B.

What is the long-term trend for Insmed's enterprise value?

Over 5 years (2020 to 2025), Insmed's enterprise value has grown at a 62.3% compound annual growth rate (CAGR), from $3.3B to $37.2B.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.